doi: 10.1001/jama.1954.02950010023009.
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases
- PMID: 13183798
- DOI: 10.1001/jama.1954.02950010023009
Item in Clipboard
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 5. Reanalysis of results based on laboratory-confirmed cases
J Am Med Assoc.
.
No abstract available
Similar articles
-
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis.J Am Med Assoc. 1952 Oct 25;150(8):757-60. doi: 10.1001/jama.1952.03680080019003. J Am Med Assoc. 1952. PMID: 12980834 No abstract available.
-
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses.J Am Med Assoc. 1953 Apr 11;151(15):1272-85. J Am Med Assoc. 1953. PMID: 13034471 No abstract available.
-
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah.J Am Med Assoc. 1952 Oct 25;150(8):739-49. doi: 10.1001/jama.1952.03680080001001. J Am Med Assoc. 1952. PMID: 12980832 No abstract available.
-
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies.J Am Med Assoc. 1952 Oct 25;150(8):750-6. doi: 10.1001/jama.1952.03680080012002. J Am Med Assoc. 1952. PMID: 12980833 No abstract available.
-
Epidemiological aspects of gamma globulin prophylaxis in poliomyelitis; a critical evaluation.AMA Am J Dis Child. 1953 Sep;86(3):311-8. doi: 10.1001/archpedi.1953.02050080321007. AMA Am J Dis Child. 1953. PMID: 13091310 No abstract available.
Cited by
-
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management.Pathogens. 2024 Dec 20;13(12):1128. doi: 10.3390/pathogens13121128. Pathogens. 2024. PMID: 39770387 Free PMC article. Review.
-
Noninvasive vaccination against infectious diseases.Hum Vaccin Immunother. 2018 Jul 3;14(7):1717-1733. doi: 10.1080/21645515.2018.1461296. Epub 2018 May 17. Hum Vaccin Immunother. 2018. PMID: 29624470 Free PMC article. Review.
-
Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.Expert Rev Vaccines. 2015;14(8):1113-23. doi: 10.1586/14760584.2015.1052800. Epub 2015 Jul 9. Expert Rev Vaccines. 2015. PMID: 26159938 Free PMC article. Review.
-
Current trends in targeted therapy for drug-resistant infections.Appl Microbiol Biotechnol. 2019 Oct;103(20):8301-8314. doi: 10.1007/s00253-019-10028-5. Epub 2019 Aug 14. Appl Microbiol Biotechnol. 2019. PMID: 31414162 Free PMC article. Review.
-
The Fight against Poliovirus Is Not Over.Microorganisms. 2023 May 17;11(5):1323. doi: 10.3390/microorganisms11051323. Microorganisms. 2023. PMID: 37317297 Free PMC article. Review.